Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arancia Industrial is a prominent Mexican conglomerate specializing in biotechnology and the production of specialized ingredients for the pharmaceutical, food, and nutrition industries. Through its various business units and joint ventures, such as Enmex (a partnership with IFF), the company produces a wide range of industrial and pharmaceutical-grade enzymes and excipients, including starches and glucose derivatives. Arancia is recognized as a leader in the Mexican biotech sector, utilizing advanced fermentation and chemical synthesis technologies to serve global markets. The company operates internationally through its Arancia International division, providing high-quality raw materials and technical solutions to life science companies worldwide. Headquartered in Guadalajara, Mexico, Arancia maintains a strong focus on R&D and sustainable manufacturing practices, with a history of innovation dating back to 1925.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arancia International.